Autres langues DSS, Inc.

Actions

DSS

US26253C2017

Temps réel estimé Cboe BZX Autres places de cotation 16:03:46 07/05/2024			Varia. 5j.	Varia. 1 janv.
1,67 ^USD	+0,60 %		-3,45 %	-30,47 %

17/04	Un juge nigérian se prononcera sur la libération sous caution du leader séparatiste le mois prochain	RE
27/03	DSS, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Al Ansari Exchange Secures Payment Card Industry Data Security Standard Validation for 2024	22/04
Nigerian judge to rule on separatist leader's bail next month	17/04
DSS, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Nigerian court denies separatist leader Kanu bail, orders trial	19/03
Privasia Technology Acquires Djava Factory for MYR1.1 Million	14/03
Eckoh inks partnership with RingCentral in US	12/03
DSS, Inc. Announces Resignation of Sassuan Samson Lee to Board of Directors	09/02
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."	30/01
DSS, Inc. and Impact Biomedical, Inc., Enters into an Amendment to the Revolving Promissory Note	22/01
Lokführer-Streik soll im Güterverkehr beginnen	09/01
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market	04/01
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan	22/12
ArcelorMittal to Release Group Audit of Safety Practices in September	22/12
ArcelorMittal : l'évaluation de la sécurité confiée à dss+	22/12
Steelmaker ArcelorMittal Hires Firm to Conduct Safety Audit	22/12
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years	28/11
Impact Biomedical Inc. Files Current Report on Form 8-K	15/11
DSS, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
DSS Inc. Wins Patent Dispute with Nichia Corporation	14/11
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock	08/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues DSS, Inc.

Actions

DSS

US26253C2017

Autres langues

Filtres